Adipose tissue and adipocyte dysregulation

Diabetes and Metabolism

Volumn 40, Issue 1, 2014, Pages 16-28

  Lafontan, M ^a,b  

^a CHU RANGUEIL   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Adipocyte hypertrophy; Adipogenesis; Blood flow; Fat cells; Inflammation; Insulin resistance; Lipogenesis; Lipolysis; Macrophages

Indexed keywords

ADIPOCYTOKINE;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ADIPOSE TISSUE BLOOD FLOW; ANGIOGENESIS; CELL INFILTRATION; CYTOKINE PRODUCTION; DISEASE COURSE; EXTRACELLULAR MATRIX; HUMAN; IMMUNOCOMPETENT CELL; INSULIN RESISTANCE; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; MACROPHAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; REVIEW; TISSUE EXPANSION;

ADIPOCYTE HYPERTROPHY; ADIPOGENESIS; BLOOD FLOW; FAT CELLS; INFLAMMATION; INSULIN RESISTANCE; LIPOGENESIS; LIPOLYSIS; MACROPHAGES;

ADIPOCYTES; ADIPOGENESIS; ADIPOKINES; ADIPOSE TISSUE; ENERGY METABOLISM; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIPOGENESIS; LIPOLYSIS; MALE; OBESITY; OXIDATIVE STRESS;

EID: 84893722362     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2013.08.002     Document Type: Review

References (117)

1. Gregor M.F., Hotamisligil G.S. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011, 29:415-445.
2. Tchernof A., Despres J.P. Pathophysiology of human visceral obesity: an update. Physiol Rev 2013, 93:359-404.
3. McQuaid S.E., Humphreys S.M., Hodson L., Fielding B.A., Karpe F., Frayn K.N. Femoral adipose tissue may accumulate the fat that has been recycled as VLDL and nonesterified fatty acids. Diabetes 2010, 59:2465-2473.
4. Manolopoulos K.N., Karpe F., Frayn K.N. Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond) 2010, 34:949-959.
5. Tchkonia T., Thomou T., Zhu Y., Karagiannides I., Pothoulakis C., Jensen M.D., et al. Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab 2013, 17:644-656.
6. Zhang H.M., Chen L.L., Wang L., Xu S., Wang X., Yi L.L., et al. Macrophage infiltrates with high levels of Toll-like receptor 4 expression in white adipose tissues of male Chinese. Nutr Metab Cardiovasc Dis 2009, 19:736-743.
7. Meijer K., de Vries M., Al-Lahham S., Bruinenberg M., Weening D., Dijkstra M., et al. Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages. PLoS One 2011, 6:e17154.
8. Wang Y. Small lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2. Br J Pharmacol 2012, 165:603-621.
9. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011, 11:85-97.
10. Sotornik R., Brassard P., Martin E., Yale P., Carpentier A.C., Ardilouze J.L. Update on adipose tissue blood flow regulation. Am J Physiol Endocrinol Metab 2012, 302:E1157-E1170.
11. Trayhurn P., Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004, 92:347-355.
12. Virtue S., Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome - an allostatic perspective. Biochim Biophys Acta 2010, 1801:338-349.
13. Unger R.H., Clark G.O., Scherer P.E., Orci L. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 2010, 1801:209-214. [Review].
14. Sorensen T.I., Virtue S., Vidal-Puig A. Obesity as a clinical and public health problem: is there a need for a new definition based on lipotoxicity effectsα. Biochim Biophys Acta 2010, 1801:400-404.
15. Pasarica M., Sereda O.R., Redman L.M., Albarado D.C., Hymel D.T., Roan L.E., et al. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 2009, 58:718-725.
16. Ye J., Gao Z., Yin J., He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 2007, 293:E1118-E1128.
17. Tang W., Zeve D., Suh J.M., Bosnakovski D., Kyba M., Hammer R.E., et al. White fat progenitor cells reside in the adipose vasculature. Science 2008, 322:583-586.
18. Rutkowski J.M., Davis K.E., Scherer P.E. Mechanisms of obesity and related pathologies: the macro- and microcirculation of adipose tissue. FEBS J 2009, 276:5738-5746.
19. Pond C.M., Mattacks C.A. In vivo evidence for the involvement of the adipose tissue surrounding lymph nodes in immune responses. Immunol Lett 1998, 63:159-167.
20. Manolopoulos K.N., Karpe F., Frayn K.N. Marked resistance of femoral adipose tissue blood flow and lipolysis to adrenaline in vivo. Diabetologia. 2012, 55:3029-3037.
21. Summers L.K., Callow J., Samra J.S., Macdonald I.A., Matthews D.R., Frayn K.N. The effect on adipose tissue blood flow of isoenergetic meals containing different amounts and types of fat. Int J Obes Relat Metab Disord 2001, 25:1294-1299.
22. Karpe F., Fielding B.A., Ilic V., Macdonald I.A., Summers L.K., Frayn K.N. Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity. Diabetes 2002, 51:2467-2473.
23. Dimitriadis G., Lambadiari V., Mitrou P., Maratou E., Boutati E., Panagiotakos D.B., et al. Impaired postprandial blood flow in adipose tissue may be an early marker of insulin resistance in type 2 diabetes. Diabetes Care 2007, 30:3128-3130.
24. Tobin L., Simonsen L., Bulow J. The dynamics of the microcirculation in the subcutaneous adipose tissue is impaired in the postprandial state in type 2 diabetes. Clin Physiol Funct Imaging 2011, 31:458-463.
25. Goossens G.H., Bizzarri A., Venteclef N., Essers Y., Cleutjens J.P., Konings E., et al. Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation. Circulation 2011, 124:67-76.
26. Hodson L., Humphreys S.M., Karpe F., Frayn K.N. Metabolic signatures of human adipose tissue hypoxia in obesity. Diabetes 2013, 62:1417-1425.
27. Trayhurn P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev 2013, 93:1-21.
28. Goossens G.H., Blaak E.E. Adipose tissue oxygen tension: implications for chronic metabolic and inflammatory diseases. Curr Opin Clin Nutr Metab Care 2012, 15:539-546.
29. Frayn K.N. Adipose tissue as a buffer for daily lipid flux. Diabetologia 2002, 45:1201-1210.
30. Petersen K.F., Shulman G.I. Etiology of insulin resistance. Am J Med 2006, 119(5 Suppl. 1):S10-S16.
31. Eckel R.H. Insulin resistance: an adaptation for weight maintenance. Lancet 1992, 340:1452-1453.
32. Lafontan M., Langin D. Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 2009, 48:275-297.
33. Wang H., Eckel R.H. Lipoprotein lipase: from gene to obesity. Am J Physiol Endocrinol Metab 2009, 297:E271-E288. [Review].
34. Young S.G., Zechner R. Biochemistry and pathophysiology of intravascular and intracellular lipolysis. Genes Dev 2013, 27:459-484.
35. Spalding K.L., Arner E., Westermark P.O., Bernard S., Buchholz B.A., Bergmann O., et al. Dynamics of fat cell turnover in humans. Nature 2008, 453:783-787.
36. Arner P., Bernard S., Salehpour M., Possnert G., Liebl J., Steier P., et al. Dynamics of human adipose lipid turnover in health and metabolic disease. Nature 2011, 478:110-113.
37. Beigneux A.P., Davies B.S., Gin P., Weinstein M.M., Farber E., Qiao X., et al. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab 2007, 5:279-291.
38. Brasaemle D.L. Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J Lipid Res 2007, 48:2547-2559.
39. Puri V., Ranjit S., Konda S., Nicoloro S.M., Straubhaar J., Chawla A., et al. Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc Natl Acad Sci U S A 2008, 105:7833-7838.
40. McQuaid S.E., Hodson L., Neville M.J., Dennis A.L., Cheeseman J., Humphreys S.M., et al. Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat depositionα. Diabetes 2011, 60:47-55.
41. Sethi J.K., Vidal-Puig A.J. Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res 2007, 48:1253-1262.
42. Arner P., Arner E., Hammarstedt A., Smith U. Genetic predisposition for Type 2 diabetes, but not for overweight/obesity, is associated with a restricted adipogenesis. PLoS One 2011, 6:e18284.
43. Gustafson B., Smith U., The W.N.T. inhibitor Dickkopf 1 and bone morphogenetic protein 4 rescue adipogenesis in hypertrophic obesity in humans. Diabetes 2012, 61:1217-1224.
44. Diraison F., Dusserre E., Vidal H., Sothier M., Beylot M. Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity. Am J Physiol Endocrinol Metab 2002, 282:E46-E51.
45. Roberts R., Hodson L., Dennis A.L., Neville M.J., Humphreys S.M., Harnden K.E., et al. Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. Diabetologia 2009, 52:882-890.
46. Karpe F., Dickmann J.R., Frayn K.N. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 2011, 60:2441-2449.
47. Laurencikiene J., Skurk T., Kulyte A., Heden P., Astrom G., Sjolin E., et al. Regulation of lipolysis in small and large fat cells of the same subject. J Clin Endocrinol Metab 2011, 96:E2045-E2049.
48. Bezaire V., Mairal A., Ribet C., Lefort C., Girousse A., Jocken J., et al. Contribution of adipose triglyceride lipase and hormone-sensitive lipase to lipolysis in hMADS adipocytes. J Biol Chem 2009, 284:18282-18291.
49. Lafontan M., Berlan M. Fat cell alpha 2-adrenoceptors: the regulation of fat cell function and lipolysis. Endocr Rev 1995, 16:716-738.
50. Langin D., Arner P. Importance of TNFalpha and neutral lipases in human adipose tissue lipolysis. Trends Endocrinol Metab 2006, 17:314-320.
51. Divoux A., Tordjman J., Lacasa D., Veyrie N., Hugol D., Aissat A., et al. Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes 2010, 59:2817-2825.
52. Arner E., Westermark P.O., Spalding K.L., Britton T., Ryden M., Frisen J., et al. Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 2010, 59:105-109.
53. Weyer C., Foley J.E., Bogardus C., Tataranni P.A., Pratley R.E. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000, 43:1498-1506.
54. Guilherme A., Virbasius J.V., Puri V., Czech M.P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008, 9:367-377.
55. McLaughlin T., Sherman A., Tsao P., Gonzalez O., Yee G., Lamendola C., et al. Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia 2007, 50:1707-1715.
56. Tchoukalova Y.D., Koutsari C., Karpyak M.V., Votruba S.B., Wendland E., Jensen M.D. Subcutaneous adipocyte size and body fat distribution. Am J Clin Nutr 2008, 87:56-63.
57. Drolet R., Richard C., Sniderman A.D., Mailloux J., Fortier M., Huot C., et al. Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond) 2008, 32:283-291.
58. Farnier C., Krief S., Blache M., Diot-Dupuy F., Mory G., Ferre P., et al. Adipocyte functions are modulated by cell size change: potential involvement of an integrin/ERK signalling pathway. Int J Obes Relat Metab Disord 2003, 27:1178-1186.
59. Varlamov O., Somwar R., Cornea A., Kievit P., Grove K.L., Roberts C.T. Single-cell analysis of insulin-regulated fatty acid uptake in adipocytes. Am J Physiol Endocrinol Metab 2010, 299:E486-E496.
60. Bluher M., Wilson-Fritch L., Leszyk J., Laustsen P.G., Corvera S., Kahn C.R. Role of insulin action and cell size on protein expression patterns in adipocytes. J Biol Chem 2004, 279:31902-31909.
61. Cohen A.W., Combs T.P., Scherer P.E., Lisanti M.P. Role of caveolin and caveolae in insulin signaling and diabetes. Am J Physiol Endocrinol Metab 2003, 285:E1151-E1160.
62. Le Lay S., Krief S., Farnier C., Lefrere I., Le Liepvre X., Bazin R., et al. Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes. J Biol Chem 2001, 276:16904-16910.
63. Hulstrom V., Prats C., Vinten J. Adipocyte size and cellular expression of caveolar proteins analyzed by confocal microscopy. Am J Physiol Cell Physiol 2013, 304:C1168-C1175.
64. Ozcan U., Cao Q., Yilmaz E., Lee A.H., Iwakoshi N.N., Ozdelen E., et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004, 306:457-461.
65. Rasouli N., Kern P.A. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 2008, 93(11 Suppl. 1):S64-S73.
66. Kwon H., Pessin J.E. Adipokines mediate inflammation and insulin resistance. Front Endocrinol (Lausanne) 2013, 4:71.
67. Fain J.N. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2006, 74:443-477.
68. Sartipy P., Loskutoff D.J. Monocyte chemoattractant protein 1 in obesity insulin resistance. Proc Natl Acad Sci U S A 2003, 100:7265-7270.
69. Boura-Halfon S., Zick Y. Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab 2009, 296:E581-E591. [Review].
70. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J Clin Invest 2005, 115:1111-1119.
71. Zhang X., Xu A., Chung S.K., Cresser J.H., Sweeney G., Wong R.L., et al. Selective inactivation of c-Jun NH2-terminal kinase in adipose tissue protects against diet-induced obesity and improves insulin sensitivity in both liver and skeletal muscle in mice. Diabetes 2011, 60:486-495.
72. Jernas M., Palming J., Sjoholm K., Jennische E., Svensson P.A., Gabrielsson B.G., et al. Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. Faseb J 2006, 20:1540-1542.
73. Guo K.Y., Halo P., Leibel R.L., Zhang Y. Effects of obesity on the relationship of leptin mRNA expression and adipocyte size in anatomically distinct fat depots in mice. Am J Physiol Regul Integr Comp Physiol 2004, 287:R112-R119.
74. Cinti S., Mitchell G., Barbatelli G., Murano I., Cerezi E., Faloia E., et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005, 46:2347-2355.
75. Duffaut C., Galitzky J., Lafontan M., Bouloumie A. Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem Biophys Res Commun 2009, 384:482-485.
76. Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009, 15:914-920.
77. Winer S., Chan Y., Paltser G., Truong D., Tsui H., Bahrami J., et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009, 15:921-929.
78. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005, 5:953-964.
79. Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007, 117:175-184.
80. Lumeng C.N., Deyoung S.M., Bodzin J.L., Saltiel A.R. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 2007, 56:16-23.
81. Sun K., Halberg N., Khan M., Magalang U.J., Scherer P.E. Selective inhibition of hypoxia-inducible factor 1alpha ameliorates adipose tissue dysfunction. Mol Cell Biol 2013, 33:904-917.
82. Curat C.A., Miranville A., Sengenes C., Diehl M., Tonus C., Busse R., et al. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004, 53:1285-1292.
83. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
84. Curat C.A., Wegner V., Sengenes C., Miranville A., Tonus C., Busse R., et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006, 49:744-747.
85. Cancello R., Tordjman J., Poitou C., Guilhem G., Bouillot J.L., Hugol D., et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006, 55:1554-1561.
86. Harman-Boehm I., Bluher M., Redel H., Sion-Vardy N., Ovadia S., Avinoach E., et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007, 92:2240-2247.
87. Bourlier V., Zakaroff-Girard A., Miranville A., De Barros S., Maumus M., Sengenes C., et al. Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation 2008, 117:806-815.
88. Cancello R., Henegar C., Viguerie N., Taleb S., Poitou C., Rouault C., et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005, 54:2277-2286.
89. Bouloumie A., Curat C.A., Sengenes C., Lolmede K., Miranville A., Busse R. Role of macrophage tissue infiltration in metabolic diseases. Curr Opin Clin Nutr Metab Care 2005, 8:347-354.
90. Lumeng C.N., Saltiel A.R. Inflammatory links between obesity and metabolic disease. J Clin Invest 2011, 121:2111-2117.
91. Halberg N., Khan T., Trujillo M.E., Wernstedt-Asterholm I., Attie A.D., Sherwani S., et al. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 2009, 29:4467-4483.
92. Krishnan J., Danzer C., Simka T., Ukropec J., Walter K.M., Kumpf S., et al. Dietary obesity-associated Hif1alpha activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system. Genes Dev 2012, 26:259-270.
93. Jiang C., Qu A., Matsubara T., Chanturiya T., Jou W., Gavrilova O., et al. Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice. Diabetes 2011, 60:2484-2495.
94. Pajvani U.B., Trujillo M.E., Combs T.P., Iyengar P., Jelicks L., Roth K.A., et al. Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nat Med 2005, 11:797-803.
95. Alkhouri N., Gornicka A., Berk M.P., Thapaliya S., Dixon L.J., Kashyap S., et al. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J Biol Chem 2010, 285:3428-3438.
96. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006, 116:1494-1505.
97. Weisberg S.P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006, 116:115-124.
98. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821-1830.
99. Pal D., Dasgupta S., Kundu R., Maitra S., Das G., Mukhopadhyay S., et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med 2012, 18:1279-1285.
100. Stefan N., Haring H.U. Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans. Nat Med 2013, 19:394-395.
101. Kosteli A., Sugaru E., Haemmerle G., Martin J.F., Lei J., Zechner R., et al. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest 2010, 120:3466-3479.
102. Granneman J.G., Li P., Zhu Z., Lu Y. Metabolic and cellular plasticity in white adipose tissue I: effects of beta3-adrenergic receptor activation. Am J Physiol Endocrinol Metab 2005, 289:E608-E616.
103. Henegar C., Tordjman J., Achard V., Lacasa D., Cremer I., Guerre-Millo M., et al. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol 2008, 9:R14.
104. Keophiphath M., Achard V., Henegar C., Rouault C., Clement K., Lacasa D. Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes. Mol Endocrinol 2009, 23:11-24.
105. Pasarica M., Gowronska-Kozak B., Burk D., Remedios I., Hymel D., Gimble J., et al. Adipose tissue collagen VI in obesity. J Clin Endocrinol Metab 2009, 94:5155-5162.
106. Park J., Euhus D.M., Scherer P.E. Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr Rev 2011, 32:550-570.
107. Park J., Scherer P.E. Adipocyte-derived endotrophin promotes malignant tumor progression. J Clin Invest 2012, 122:4243-4256.
108. Tchoukalova Y.D., Koutsari C., Votruba S.B., Tchkonia T., Giorgadze N., Thomou T., et al. Sex- and depot-dependent differences in adipogenesis in normal-weight humans. Obesity (Silver Spring) 2010, 18:1875-1880.
109. Isakson P., Hammarstedt A., Gustafson B., Smith U. Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation. Diabetes 2009, 58:1550-1557.
110. Bowers R.R., Lane M.D. Wnt signaling and adipocyte lineage commitment. Cell Cycle 2008, 7:1191-1196.
111. Cao Y. Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat Rev Drug Discov 2010, 9:107-115.
112. Ledoux S., Queguiner I., Msika S., Calderari S., Rufat P., Gasc J.M., et al. Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity. Diabetes 2008, 57:3247-3257.
113. Gealekman O., Guseva N., Hartigan C., Apotheker S., Gorgoglione M., Gurav K., et al. Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation 2011, 123:186-194.
114. Baptista L.S., da Silva K.R., da Pedrosa C.S., Claudio-da-Silva C., Carneiro J.R., Aniceto M., et al. Adipose tissue of control and ex-obese patients exhibit differences in blood vessel content and resident mesenchymal stem cell population. Obes Surg 2009, 19:1304-1312.
115. Lemoine A.Y., Ledoux S., Queguiner I., Calderari S., Mechler C., Msika S., et al. Link between adipose tissue angiogenesis and fat accumulation in severely obese subjects. J Clin Endocrinol Metab 2012, 97:E775-E780.
116. Villaret A., Galitzky J., Decaunes P., Esteve D., Marques M.A., Sengenes C., et al. Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence. Diabetes 2010, 59:2755-2763.
117. Seok J., Warren H.S., Cuenca A.G., Mindrinos M.N., Baker H.V., Xu W., et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 2013, 110:3507-3512.